Validation of Oncomine™ Immuno-Oncology NGS Assays at Q2 Solutions
Trends, Outcomes and Results
This presentation was given at ThermoFisher's Oncology network meeting in May 2019.
Download the presentation to learn:
- How Q2 Solutions leverages the ThermoFisher Oncomine™ Immuno-Oncology next generation sequencing (NGS) assays to support our translational research objectives
- Q2 Solutions validation trends, outcomes and results of the Oncomine™ Immuno-Oncology NGS assays